Anticancer Therapy
Hsp90 activation and cell cycle regulation discussed
Published in Vaccine Weekly, May 11th, 2005
According to recent research published in the journal Cell Cycle, "The widely-expressed molecular chaperone heat shock protein 90 (Hsp90) regulates several important cellular processes via its repertoire of 'client' proteins."
"Signal transduction pathways controlled by Hsp90 contribute to all major components of the malignant phenotype, so Hsp90 inhibitors are under investigation as anticancer agents. Since Hsp90 is also expressed at high levels in many normal tissues, it was unclear why Hsp90 inhibitors such as 17-allylamino-geldanamycin (17-AAG) have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-05-11)
More Articles from Vaccine Weekly
- Alzheimer Disease
Anti-A beta antibody isotypes effective against A-beta in TgCRND8 brain - Influenza Vaccine
Inactivated influenza vaccine prevents influenza in diabetic mice - Streptococcus Vaccine
Leucine-rich repeat protein antigen from streptococci elicits immunity - Tuberculosis Vaccine
Prescreening program tested a wide range of tuberculosis vaccines - Vaccine Development
Visualization of B-cell response aids selection of vaccine immunogens - Arthritis
Inhibitory co-receptor is protective in suppression of arthritis - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
